Suppr超能文献

替莫唑胺放化疗后成人弥漫性脑胶质瘤靶区勾画的观察:复发模式及预测因素分析。

Observation of the delineation of the target volume of radiotherapy in adult-type diffuse gliomas after temozolomide-based chemoradiotherapy: analysis of recurrence patterns and predictive factors.

机构信息

Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China.

Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, China.

出版信息

Radiat Oncol. 2023 Jan 23;18(1):16. doi: 10.1186/s13014-023-02203-w.

Abstract

BACKGROUND

Radiation therapy is the cornerstone of treatment for adult-type diffuse gliomas, but recurrences are inevitable. Our study assessed the prognosis and recurrence pattern of different radiotherapy volumes after temozolomide-based chemoradiation in our institution.

METHODS

The treatment plans were classified into two groups, the plan 1 intentionally involved the entire edema area while plan 2 did not. Retrospectively investigate the differences in outcomes of 118 adult-type diffuse gliomas patients between these two treatment plans. Then, patients who underwent relapse were selected to analyze their recurrence patterns. Continuous dynamic magnetic resonance images (MRI) were collected to categorized the recurrence patterns into central, in-field, marginal, distant, and cerebrospinal fluid dissemination (CSF-d) recurrence. Finally, the clinical and molecular characteristics which influenced progression were analyzed.

RESULTS

Plan 1 (n = 63) showed a median progression-free survival (PFS) and overall survival (OS) of 9.5 and 26.4 months while plan 2 (n = 55) showed a median PFS and OS of 9.4 and 36.5 months (p = 0.418; p = 0.388). Treatment target volume had no effect on the outcome in patients with adult-type diffuse gliomas. And there was no difference in radiation toxicity (p = 0.388). Among the 90 relapsed patients, a total of 58 (64.4%) patients had central recurrence, 10 (11.1%) patients had in-field recurrence, 3 (3.3%) patients had marginal recurrence, 11 (12.2.%) patients had distant recurrence, and 8 (8.9%) patients had CSF-d recurrence. By treatment plans, the recurrence patterns were similar and there was no significant difference in survival. Reclassifying the progression pattern into local and non-local groups, we observed that oligodendroglioma (n = 10) all relapsed in local and no difference in PFS and OS between the two groups (p > 0.05). Multivariable analysis showed that subventricular zone (SVZ) involvement was the independent risk factor for non-local recurrence in patients with GBM (p < 0.05).

CONCLUSION

In our study, deliberately including or not the entire edema had no impact on prognosis and recurrence. Patients with varied recurrence patterns had diverse clinical and genetic features.

摘要

背景

放射治疗是成人弥漫性胶质瘤治疗的基石,但复发是不可避免的。我们的研究评估了我们机构在替莫唑胺化疗后不同放射治疗体积的预后和复发模式。

方法

将治疗计划分为两组,计划 1 有意包含整个水肿区,而计划 2 则不包含。回顾性调查这两种治疗方案在 118 例成人弥漫性胶质瘤患者中的结果差异。然后,选择接受复发的患者来分析他们的复发模式。收集连续动态磁共振图像(MRI),将复发模式分为中央、场内、边缘、远处和脑脊液播散(CSF-d)复发。最后,分析影响进展的临床和分子特征。

结果

计划 1(n=63)的中位无进展生存期(PFS)和总生存期(OS)分别为 9.5 和 26.4 个月,而计划 2(n=55)分别为 9.4 和 36.5 个月(p=0.418;p=0.388)。治疗靶体积对成人弥漫性胶质瘤患者的结果没有影响。放射毒性也没有差异(p=0.388)。在 90 例复发患者中,共有 58 例(64.4%)患者出现中央复发,10 例(11.1%)患者出现场内复发,3 例(3.3%)患者出现边缘复发,11 例(12.2.)患者出现远处复发,8 例(8.9%)患者出现 CSF-d 复发。根据治疗计划,复发模式相似,两组间生存无显著差异。将进展模式重新分类为局部和非局部组,我们观察到少突胶质细胞瘤(n=10)均在局部复发,两组间 PFS 和 OS 无差异(p>0.05)。多变量分析显示,侧脑室下区(SVZ)受累是胶质母细胞瘤(GBM)患者非局部复发的独立危险因素(p<0.05)。

结论

在我们的研究中,有意包含或不包含整个水肿区对预后和复发没有影响。具有不同复发模式的患者具有不同的临床和遗传特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f09/9872393/606263bb813b/13014_2023_2203_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验